Genetics of keloid scarring

Archives of Dermatological Research

Volumn 302, Issue 5, 2010, Pages 319-339

  Shih, Barbara ^a   Bayat, Ardeshir ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cutaneous fibrosis; Gene expression ,Genotype phenotype association; Genetics; Inheritance; Keloid disease; Keloid scarring; Linkage; Predisposition; Susceptibility

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; ELASTIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBRIN; FIBRONECTIN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN KINASE B; PROTEIN P53; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; SOMATOMEDIN; TRANSCRIPTION FACTOR RUNX3; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; HLA ANTIGEN; SERPINE1 PROTEIN, HUMAN;

AFRICAN AMERICAN; APOPTOSIS; AUTOSOMAL DOMINANT INHERITANCE; CASE CONTROL STUDY; CHINESE; CHROMOSOME 2Q; CHROMOSOME 7P; ETHNIC GROUP; ETHNICITY; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HERITABILITY; HUMAN; IMMUNOGENETICS; INHERITANCE; JAPANESE; KELOID; LINKAGE ANALYSIS; MEDLINE; MICROARRAY ANALYSIS; PREVALENCE; PRIORITY JOURNAL; SEARCH ENGINE; SHORT SURVEY; TWINS; CLINICAL TRIAL (TOPIC); DNA MICROARRAY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; SCAR;

APOPTOSIS; CICATRIX; CLINICAL TRIALS AS TOPIC; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HLA ANTIGENS; HUMANS; INHERITANCE PATTERNS; KELOID; MITOGEN-ACTIVATED PROTEIN KINASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 77953198604     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-009-1014-y     Document Type: Short Survey

References (149)

1. Abderrahmani R, Francois A, Buard V, Benderitter M, Sabourin JC, Crandall DL, Milliat F (2009) Effects of pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 in radiation-induced intestinal injury. Int J Radiat Oncol Biol Phys 74(3):942-948
2. Akaishi S, Ogawa R, Hyakusoku H (2008) Keloid and hypertrophic scar: neurogenic inflammation hypotheses. Med Hypotheses 71(1):32-38
3. Alaish SM, Yager DR, Diegelmann RF, Cohen IK (1995) Hyaluronic acid metabolism in keloid fibroblasts. J Pediatr Surg 30(7):949-952
4. Alonso PE, Rioja LF, Pera C (2008) Keloids: a viral hypothesis. Med Hypotheses 70(1):156-166
5. Amadeu TP, Braune AS, Porto LC, Desmouliere A, Costa AM (2004) Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids. Wound Repair Regen 12(2):169-174
6. Bayat A, Arscott G, Ollier WE, Ferguson MW, McGrouther DA (2003) "Aggressive keloid": a severe variant of familial keloid scarring. J R Soc Med 96(11):554-555
7. Bayat A, Arscott G, Ollier WE, McGrouther DA, Ferguson MW (2005) Keloid disease: clinical relevance of single versus multiple site scars. Br J Plast Surg 58(1):28-37
8. Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW (2002) Genetic susceptibility to keloid disease and transforming growth factor beta 2 polymorphisms. Br J Plast Surg 55(4):283-286
9. Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW (2003) Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg 111(2):535-543 (discussion 544-536)
10. Arch Dermatol Res (2010) 302:319-339 335
11. Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW (2004) Genetic susceptibility to keloid disease: transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease. Exp Dermatol 13(2):120-124
12. Bayat A, McGrouther DA, Ferguson MW (2003) Skin scarring. BMJ 326(7380):88-92
13. Bayat A, Walter JM, Bock O, Mrowietz U, Ollier WE, Ferguson MW (2005) Genetic susceptibility to keloid disease: mutation screening of the TGFbeta3 gene. Br J Plast Surg 58(7):914-921
14. Beanes SR, Hu FY, Soo C, Dang CM, Urata M, Ting K, Atkinson JB, Benhaim P, Hedrick MH, Lorenz HP (2002) Confocal microscopic analysis of scarless repair in the fetal rat: defining the transition. Plast Reconstr Surg 109(1):160-170
15. Berman B, Bieley HC (1996) Adjunct therapies to surgical management of keloids. Dermatol Surg 22(2):126-130
16. Bloom D (1956) Heredity of keloids; review of the literature and report of a family with multiple keloids in five generations. N Y State J Med 56(4):511-519
17. Boyce DE, Ciampolini J, Ruge F, Murison MS, Harding KG (2001) Inflammatory-cell subpopulations in keloid scars. Br J Plast Surg 54(6):511-516
18. Boyce DE, Jones WD, Ruge F, Harding KG, Moore K (2000) The role of lymphocytes in human dermal wound healing. Br J Dermatol 143(1):59-65
19. Brown BC, McKenna SP, Siddhi K, McGrouther DA, Bayat A (2008) The hidden cost of skin scars: quality of life after skin scarring. J Plast Reconstr Aesthet Surg 61(9):1049-1058
20. Brown JJ, Bayat A (2009) Genetic susceptibility to raised dermal scarring. Br J Dermatol 161(1):8-18
21. Brown JJ, Ollier W, Arscott G, Ke X, Lamb J, Day P, Bayat A (2008) Genetic susceptibility to keloid scarring: SMAD gene SNP frequencies in Afro-Caribbeans. Exp Dermatol 17(7):610-613
22. Brown JJ, Ollier W, Thomson W, Bayat A (2008) Positive association of HLA-DRB1*15 with Dupuytren's disease in Caucasians. Tissue Antigens 72(2):166-170
23. Brown JJ, Ollier WE, Thomson W, Bayat A (2008) Positive association of HLA-DRB1*15 with keloid disease in Caucasians. Int J Immunogenet 35(4-5):303-307
24. Brown RL, Ormsby I, Doetschman TC, Greenhalgh DG (1995) Wound healing in the transforming growth factor-beta-deficient mouse. Wound Repair Regen 3(1):25-36
25. Butler PD, Longaker MT, Yang GP (2008) Current progress in keloid research and treatment. J Am Coll Surg 206(4):731-741
26. Char F (1971) Ehlers-Danlos syndrome. Birth Defects Orig Artic Ser 7(8):300-302
27. Chen W, Fu X, Sun X, Sun T, Zhao Z, Sheng Z (2003) Analysis of differentially expressed genes in keloids and normal skin with cDNA microarray. J Surg Res 113(2):208-216
28. Chen Y, Gao JH, Liu XJ, Yan X, Song M (2006) Characteristics of occurrence for Han Chinese familial keloids. Burns 32(8):1052-1059
29. Chen Y, Gao JH, Liu XJ, Yan X, Song M (2006) Linkage analysis of keloid susceptibility loci on chromosome 7p11 in a Chinese pedigree. Nan Fang Yi Ke Da Xue Xue Bao 26(5):623- 625, 637
30. Chen Y, Gao JH, Yan X, Song M, Liu XJ (2007) Location of predisposing gene for one Han Chinese keloid pedigree. Zhonghua Zheng Xing Wai Ke Za Zhi 23(2):137-140
31. Chin GS, Liu W, Peled Z, Lee TY, Steinbrech DS, Hsu M, Longaker MT (2001) Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg 108(2):423-429
32. Chodon T, Sugihara T, Igawa HH, Funayama E, Furukawa H (2000) Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance. Am J Pathol 157(5):1661-1669
33. Clark JA, Turner ML, Howard L, Stanescu H, Kleta R, Kopp JB (2009) Description of familial keloids in five pedigrees: evidence for autosomal dominant inheritance and phenotypic heterogeneity. BMC Dermatol 9:8
34. Craig SS, DeBlois G, Schwartz LB (1986) Mast cells in human keloid, small intestine, and lung by an immunoperoxidase technique using a murine monoclonal antibody against tryptase. Am J Pathol 124(3):427-435
35. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA (2003) DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 4(5):P3
36. Derynck R, Zhang YE (2003) Smad-dependent and Smadindependent pathways in TGF-beta family signalling. Nature 425(6958):577-584
37. Dienz O, Rincon M (2009) The effects of IL-6 on CD4 T cell responses. Clin Immunol 130(1):27-33
38. Dyment DA, Herrera BM, Cader MZ, Willer CJ, Lincoln MR, Sadovnick AD, Risch N, Ebers GC (2005) Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 14(14):2019-2026
39. Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, Simon RH (1996) Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97(1):232-237
40. Faler BJ, Macsata RA, Plummer D, Mishra L, Sidawy AN (2006) Transforming growth factor-beta and wound healing. Perspect Vasc Surg Endovasc Ther 18(1):55-62
41. Fattal PG, Schneider DJ, Sobel BE, Billadello JJ (1992) Posttranscriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1. J Biol Chem 267(18):12412-12415
42. Fong EP, Bay BH (2002) Keloids-the sebum hypothesis revisited. Med Hypotheses 58(4):264-269
43. Frantz FW, Bettinger DA, Haynes JH, Johnson DE, Harvey KM, Dalton HP, Yager DR, Diegelmann RF, Cohen IK (1993) Biology of fetal repair: the presence of bacteria in fetal wounds induces an adult-like healing response. J Pediatr Surg 28(3):428-433 (discussion 433-424)
44. Friedman DW, Boyd CD, Mackenzie JW, Norton P, Olson RM, Deak SB (1993) Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res 55(2):214-222
45. Fujiwara M, Muragaki Y, Ooshima A (2005) Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Arch Dermatol Res 297(4):161-169
46. Fukatsu A, Matsuo S, Yuzawa Y, Miyai H, Futenma A, Kato K (1993) Expression of interleukin 6 and major histocompatibility complex molecules in tubular epithelial cells of diseased human kidneys. Lab Invest 69(1):58-67
47. Ghazizadeh M (2007) Essential role of IL-6 signaling pathway in keloid pathogenesis. J Nippon Med Sch 74(1):11-22 (Pubitemid 46364339)
48. Ghazizadeh M, Tosa M, Shimizu H, Hyakusoku H, Kawanami O (2007) Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol 127(1):98-105 (Pubitemid 46005666)
49. Goeminne L (1968) A new probably X-linked inherited syndrome: congenital muscular torticollis, multiple keloids cryptorchidism and renal dysplasia. Acta Genet Med Gemellol (Roma) 17(3):439-467
50. Gonzalez-Martinez R, Marin-Bertolin S, Amorrortu-Velayos J (1995) Association between keloids and Dupuytren's disease: case report. Br J Plast Surg 48(1):47-48
51. Goodfellow A, Emmerson RW, Calvert HT (1980) Rubinstein- Taybi syndrome and spontaneous keloids. Clin Exp Dermatol 5(3):369-370
52. GuppyM(2002) The hypoxic core: a possible answer to the cancer paradox. Biochem Biophys Res Commun 299(4):676-680
53. Gurtner GC, Werner S, Barrandon Y, Longaker MT (2008) Wound repair and regeneration. Nature 453(7193):314-321
54. Haisa M, Okochi H, Grotendorst GR (1994) Elevated levels of PDGF alpha receptors in keloid fibroblasts contribute to an enhanced response to PDGF. J Invest Dermatol 103(4):560-563
55. Hambrick GW Jr, Carter DM (1966) Pachydermoperiostosis. Touraine-Solente-Gole syndrome. Arch Dermatol 94(5):594-607
56. Heyen CA, Delk PR, Bull MJ, Weaver DD (2008) A report of an apparent new genetic syndrome consisting of joint contractures, keloids, large optic cup-to-disc ratio and renal stones. Am J Med Genet A 146A(24):3120-3125
57. Hocevar BA, Howe PH (2000) Analysis of TGF-beta-mediated synthesis of extracellular matrix components. Methods Mol Biol 142:55-65
58. Hu ZF, Gao JH, Li W, Song YB, Li CL (2006) Differential gene expression profile of keloids: a study with cDNA microarray. Nan Fang Yi Ke Da Xue Xue Bao 26(3):308-312
59. HuangDa W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44-57
60. Huse M, Muir TW, Xu L, Chen YG, Kuriyan J, Massague J (2001) The TGF beta receptor activation process: an inhibitorto substrate-binding switch. Mol Cell 8(3):671-682
61. Ishihara H, Yoshimoto H, Fujioka M, Murakami R, Hirano A, Fujii T, Ohtsuru A, Namba H, Yamashita S (2000) Keloid fibroblasts resist ceramide-induced apoptosis by overexpression of insulin-like growth factor I receptor. J Invest Dermatol 115(6):1065-1071
62. Izzi L, Attisano L (2006) Ubiquitin-dependent regulation of TGFbeta signaling in cancer. Neoplasia 8(8):677-688
63. Jagadeesan J, Bayat A (2007) Transforming growth factor beta (TGFbeta) and keloid disease. Int J Surg 5(4):278-285
64. Kamamoto F, Paggiaro AO, Rodas A, Herson MR, Mathor MB, Ferreira MC (2003) A wound contraction experimental model for studying keloids and wound-healing modulators. Artif Organs 27(8):701-705
65. Kaminska B, Wesolowska A, Danilkiewicz M (2005) TGF beta signalling and its role in tumour pathogenesis. Acta Biochim Pol 52(2):329-337
66. Kang JS, Liu C, Derynck R (2009) New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol 19(8):385-394
67. Kikuchi K, Kadono T, Takehara K (1995) Effects of various growth factors and histamine on cultured keloid fibroblasts. Dermatology 190(1):4-8
68. Kischer CW (1992) The microvessels in hypertrophic scars, keloids and related lesions: a review. J Submicrosc Cytol Pathol 24(2):281-296
69. Kischer CW, Hendrix MJ (1983) Fibronectin (FN) in hypertrophic scars and keloids. Cell Tissue Res 231(1):29-37
70. Kischer CW, Thies AC, Chvapil M (1982) Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. Hum Pathol 13(9):819-824
71. Kohler HP, Grant PJ (2000) Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 342(24):1792-1801
72. Kuo YR, Wu WS, Wang FS (2007) Flashlamp pulsed-dye laser suppressed TGF-beta1 expression and proliferation in cultured keloid fibroblasts is mediated by MAPK pathway. Lasers Surg Med 39(4):358-364
73. Kurwa AR (1979) Rubinstein-Taybi syndrome and spontaneous keloids. Clin Exp Dermatol 4(2):251-254
74. Kutz SM, Hordines J, McKeown-Longo PJ, Higgins PJ (2001) TGF-beta1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion. J Cell Sci 114(Pt 21):3905-3914
75. Ladin DA, Hou Z, Patel D, McPhail M, Olson JC, Saed GM, Fivenson DP (1998) p53 and apoptosis alterations in keloids and keloid fibroblasts. Wound Repair Regen 6(1):28-37
76. Lanning DA, Diegelmann RF, Yager DR, Wallace ML, Bagwell CE, Haynes JH (2000) Myofibroblast induction with transforming growth factor-beta1 and -beta3 in cutaneous fetal excisional wounds. J Pediatr Surg 35(2):183-187 (discussion 187-188)
77. Lee TY, Chin GS, Kim WJ, Chau D, Gittes GK, Longaker MT (1999) Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 43(2):179-184
78. LeFlore IC (1980) Misconceptions regarding elective plastic surgery in the black patient. J Natl Med Assoc 72(10):947-948
79. Li Y, Han B, Li K, Jiao LR, Habib N, Wang H (1999) TGF-beta 1 inhibits HLA-DR and beta 2-microglobulin expression in HeLa cells induced with r-IFN. Transplant Proc 31(5):2143-2145
80. Lijnen HR (2001) Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 86(1):324-333
81. Lo TC, Seckel BR, Salzman FA, Wright KA (1990) Single-dose electron beam irradiation in treatment and prevention of keloids and hypertrophic scars. Radiother Oncol 19(3):267-272
82. Lopez-Casillas F, Wrana JL, Massague J (1993) Betaglycan presents ligand to the TGF beta signaling receptor. Cell 73(7):1435-1444
83. Lu WS, Wang JF, Yang S, Xiao FL, Quan C, Cheng H, Wang PG, Zhang AP, Cai LQ, Zhang XJ (2008) Association of HLADQA1 and DQB1 alleles with keloids in Chinese Hans. J Dermatol Sci 52(2):108-117
84. Maarouf M, Schleicher U, Schmachtenberg A, Ammon J (2002) Radiotherapy in the management of keloids. Clinical experience with electron beam irradiation and comparison with X-ray therapy. Strahlenther Onkol 178(6):330-335
85. Mandal A, Imran D, Rao GS (2004) Spontaneous keloids in siblings. Ir Med J 97(8):250-251
86. Marneros AG, Norris JE, Olsen BR, Reichenberger E (2001) Clinical genetics of familial keloids. Arch Dermatol 137(11):1429-1434
87. Marneros AG, Norris JE, Watanabe S, Reichenberger E, Olsen BR (2004) Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Invest Dermatol 122(5):1126-1132
88. McCauley RL, Chopra V, Li YY, Herndon DN, Robson MC (1992) Altered cytokine production in black patients with keloids. J Clin Immunol 12(4):300-308
89. Meyer LJ, Russell SB, Russell JD, Trupin JS, Egbert BM, Shuster S, Stern R (2000) Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts. J Invest Dermatol 114(5):953-959
90. Moustakas A, Heldin CH (2005) Non-Smad TGF-beta signals. J Cell Sci 118(Pt 16):3573-3584
91. Muller-Hilke B (2009) HLA class II and autoimmunity: epitope selection vs differential expression. Acta Histochem 111(4):379-381
92. Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Shakespeare PG, Stella M, Teot L, Wood FM, Ziegler UE (2002) International clinical recommendations on scar management. Plast Reconstr Surg 110(2):560-571
93. Na GY, Seo SK, Lee SJ, Kim DW, Kim MK, Kim JC (2004) Upregulation of the NNP-1 (novel nuclear protein-1, D21S2056E) gene in keloid tissue determined by cDNA microarray and in situ hybridization. Br J Dermatol 151(6):1143-1149
94. Naitoh M, Kubota H, Ikeda M, Tanaka T, Shirane H, Suzuki S, Nagata K (2005) Gene expression in human keloids is altered from dermal to chondrocytic and osteogenic lineage. Genes Cells 10(11):1081-1091
95. Nassiri M, Woolery-Lloyd H, Ramos S, Jacob SE, Gugic D, Viciana A, Romanelli P, Elgart G, Berman B, Vincek V (2009) Gene expression profiling reveals alteration of caspase 6 and 14 transcripts in normal skin of keloid-prone patients. Arch Dermatol Res 301(2):183-188
96. O'Sullivan ST, O'Shaughnessy M, O'Connor TP (1996) Aetiology and management of hypertrophic scars and keloids. Ann R Coll Surg Engl 78(3(Pt 1)):168-175
97. Ogawa R, Mitsuhashi K, Hyakusoku H, Miyashita T (2003) Postoperative electron-beam irradiation therapy for keloids and hypertrophic scars: retrospective study of 147 cases followed for more than 18 months. Plast Reconstr Surg 111(2):547-553 (discussion 554-545)
98. Ohtsuru A, Yoshimoto H, Ishihara H, Namba H, Yamashita S (2000) Insulin-like growth factor-I (IGF-I)/IGF-I receptor axis and increased invasion activity of fibroblasts in keloid. Endocr J 47(Suppl):S41-S44
99. Omo-Dare P (1975) Genetic studies on keloid. J Natl Med Assoc 67(6):428-432
100. Peltonen J, Hsiao LL, Jaakkola S, Sollberg S, Aumailley M, Timpl R, Chu ML, Uitto J (1991) Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA. J Invest Dermatol 97(2):240-248
101. Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RC, Masuno M, Tommerup N, van Ommen GJ, Goodman RH, Peters DJ et al (1995) Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376(6538):348-351
102. Phan TT, Lim IJ, Aalami O, Lorget F, Khoo A, Tan EK, Mukhopadhyay A, Longaker MT (2005) Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions. J Pathol 207(2):232-242
103. Pohlers D, Brenmoehl J, Loffler I, Muller CK, Leipner C, Schultze-Mosgau S, Stallmach A, Kinne RW, Wolf G (2009) TGF-beta and fibrosis in different organs-molecular pathway imprints. Biochim Biophys Acta 1792(8):746-756
104. Pope FM, Martin GR, Lichtenstein JR, Penttinen R, Gerson B, Rowe DW, McKusick VA (1975) Patients with Ehlers-Danlos syndrome type IV lack type III collagen. Proc Natl Acad Sci USA 72(4):1314-1316
105. Pope FM, Martin GR, McKusick VA (1977) Inheritance of Ehlers-Danlos type IV syndrome. J Med Genet 14(3):200-204
106. Ramakrishnan KM, Thomas KP, Sundararajan CR (1974) Study of 1, 000 patients with keloids in South India. Plast Reconstr Surg 53(3):276-280
107. Reilly CF, McFall RC (1991) Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells. J Biol Chem 266(15):9419-9427
108. Rojas A, Padidam M, Cress D, Grady WM (2009) TGF-beta receptor levels regulate the specificity of signaling pathway activation and biological effects of TGF-beta. Biochim Biophys Acta 1793(7):1165-1173
109. Saed GM, Ladin D, Olson J, Han X, Hou Z, Fivenson D (1998) Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing. Arch Dermatol 134(8):963-967
110. Satish L, Babu M, Tran KT, Hebda PA, Wells A (2004) Keloid fibroblast responsiveness to epidermal growth factor and activation of downstream intracellular signaling pathways. Wound Repair Regen 12(2):183-192
111. Satish L, Lyons-Weiler J, Hebda PA, Wells A (2006) Gene expression patterns in isolated keloid fibroblasts. Wound Repair Regen 14(4):463-470
112. Sato Y, Rifkin DB (1989) Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol 109(1):309-315
113. Sawdey MS, Loskutoff DJ (1991) Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J Clin Invest 88(4):1346-1353
114. Sayah DN, Soo C, Shaw WW, Watson J, Messadi D, Longaker MT, Zhang X, Ting K (1999) Downregulation of apoptosisrelated genes in keloid tissues. J Surg Res 87(2):209-216
115. Seifert O, Bayat A, Geffers R, Dienus K, Buer J, Lofgren S, Matussek A (2008) Identification of unique gene expression patterns within different lesional sites of keloids. Wound Repair Regen 16(2):254-265
116. Seifert O, Mrowietz U (2009) Keloid scarring: bench and bedside. Arch Dermatol Res 301(4):259-272
117. Shah M, Foreman DM, Ferguson MW (1992) Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 339(8787):213-214
118. Shah M, Foreman DM, Ferguson MW (1995) Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 108(Pt 3):985-1002
119. Shang QX, Yuan R, Wang W (2000) Expression of platelet derived growth factor receptor-beta in fibroblasts of keloid. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 14(5):278-282
120. Shi W, Sun C, He B, Xiong W, Shi X, Yao D, Cao X (2004) GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor. J Cell Biol 164(2):291-300
121. Siraganian PA, Rubinstein JH, Miller RW (1989) Keloids and neoplasms in the Rubinstein-Taybi syndrome. Med Pediatr Oncol 17(6):485-491
122. Smith JC, Boone BE, Opalenik SR, Williams SM, Russell SB (2008) Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol 128(5):1298-1310
123. Souchelnytskyi S, ten Dijke P, Miyazono K, Heldin CH (1996) Phosphorylation of Ser165 in TGF-beta type I receptor modulates TGF-beta1-induced cellular responses. EMBO J 15(22):6231-6240
124. Subramanian R, White CJ, Sternbergh WC III, Ferguson DL, Gilchrist IC (2003) Nonhealing wound resulting from a foreignbody reaction to a radial arterial sheath. Catheter Cardiovasc Interv 59(2):205-206
125. Teofoli P, Barduagni S, Ribuffo M, Campanella A, De Pita O, Puddu P (1999) Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars. J Dermatol Sci 22(1):31-37
126. Toriseva M, Kahari VM (2009) Proteinases in cutaneous wound healing. Cell Mol Life Sci 66(2):203-224
127. Tosa M, Ghazizadeh M, Shimizu H, Hirai T, Hyakusoku H, Kawanami O (2005) Global gene expression analysis of keloid fibroblasts in response to electron beam irradiation reveals the involvement of interleukin-6 pathway. J Invest Dermatol 124(4):704-713
128. Tredget EE, Nedelec B, Scott PG, Ghahary A (1997) Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am 77(3):701-730
129. Tuan TL, Hwu P, Ho W, Yiu P, Chang R, Wysocki A, Benya PD (2008) Adenoviral overexpression and small interfering RNA suppression demonstrate that plasminogen activator inhibitor-1 produces elevated collagen accumulation in normal and keloid fibroblasts. Am J Pathol 173(5):1311-1325
130. Tuan TL, Nichter LS (1998) The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 4(1):19-24
131. Tuan TL,WuH, Huang EY, Chong SS, Laug W, Messadi D, Kelly P, Le A (2003) Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures. Am J Pathol 162(5):1579-1589
132. Tuan TL, Zhu JY, Sun B, Nichter LS, Nimni ME, Laug WE (1996) Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol 106(5):1007-1011
133. Wang X, Smith P, Pu LL, Kim YJ, Ko F, Robson MC (1999) Exogenous transforming growth factor beta(2) modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats. J Surg Res 87(2):194-200
134. Wang Z, Gao Z, Shi Y, Sun Y, Lin Z, Jiang H, Hou T, Wang Q, Yuan X, Zhu X et al (2007) Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts. J Plast Reconstr Aesthet Surg 60(11):1193-1199
135. Wu Y, Zhang Q, Ann DK, Akhondzadeh A, Duong HS, Messadi DV, Le AD (2004) Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor- 1 via activating ERK1/2 in keloid fibroblasts. Am J Physiol Cell Physiol 286(4):C905-C912
136. Xia W, Longaker MT, Yang GP (2006) P38 MAP kinase mediates transforming growth factor-beta2 transcription in human keloid fibroblasts. Am J Physiol Regul Integr Comp Physiol 290(3):R501-R508
137. Xia W, Phan TT, Lim IJ, Longaker MT, Yang GP (2006) Differential transcriptional responses of keloid and normal keratinocytes to serum stimulation. J Surg Res 135(1):156-163
138. Yan L, Lu XY, Wang CM, Cao R, Yin YH, Jia CS, Zhuang Q (2007) Association between p53 gene codon 72 polymorphism and keloid in Chinese population. Zhonghua Zheng Xing Wai Ke Za Zhi 23(5):428-430
139. Yan X, Gao JH, Chen Y, Song M, Liu XJ (2007) Preliminary linkage analysis and mapping of keloid susceptibility locus in a Chinese pedigree. Zhonghua Zheng Xing Wai Ke Za Zhi 23(1):32-35
140. Yoshimoto H, Ishihara H, Ohtsuru A, Akino K, Murakami R, Kuroda H, Namba H, Ito M, Fujii T, Yamashita S (1999) Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts. Am J Pathol 154(3):883-889
141. Yu H, Bock O, Bayat A, Ferguson MW, Mrowietz U (2006) Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring. J Plast Reconstr Aesthet Surg 59(3):221-229
142. Yu Q, Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14(2):163-176
143. Zhang G, Fu J, Luo S, Tang S, Liang L (2008) Relationship between mutation at 1,573 fragment of TNF receptor II gene and keloid. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 22(11):1311-1313
144. Zhang G, Jiang JJ, Luo SJ, Tang SM, Liang J, Yu Q (2008) The relationship between RUNX3 gene mutation and keloid. Zhonghua Zheng Xing Wai Ke Za Zhi 24(3):224-227
145. Zhang Q, Wu Y, Ann DK, Messadi DV, Tuan TL, Kelly AP, Bertolami CN, Le AD (2003) Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol 121(5):1005-1012
146. Zhang Q, Wu Y, Chau CH, Ann DK, Bertolami CN, Le AD (2004) Crosstalk of hypoxia-mediated signaling pathways in upregulating plasminogen activator inhibitor-1 expression in keloid fibroblasts. J Cell Physiol 199(1):89-97
147. Zhang Q, Yamaza T, Kelly AP, Shi S, Wang S, Brown J, Wang L, French SW, Le AD (2009) Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 axis. PLoS One 4(11):e7798
148. Zhuo Y, Gao J, Luo S, Zeng W, Hu Z, Lu F, Zhao Y (2005) p53 gene codon 72 polymorphism and susceptibility to keloid in Chinese population. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 19(1):28-30
149. Zhuo Y, Gao JH, Luo SQ, Zeng WS, Hu ZQ, Lu F, Zhao YZ (2005) p53 gene codon 72 polymorphism and susceptibility to keloid. Zhonghua Zheng Xing Wai Ke Za Zhi 21(3):201-203